Intravitreal gas of little value in early macular hole

Intravitreal gas of little value in early macular hole

Intravitreal expansile gas is not effective in most cases with early macular hole, according to a prospective study involving 122 patients. The patients in the study all had early, stage 2 macular holes and underwent intravitreal injection of perfluoropropane 0.2ml followed by five days' facedown positioning. The study's investigators found that only three cases (25 per cent) had hole closure with vision improvement, and of those, one developed rhegmatogenous retinal detachment (RRD) and hole re-opening. Another case with persistent hole also developed RRD. In contrast, in seven of the nine cases without hole closure and the one where the hole re-opened had vitrectomy, all had hole closure and vision improvement.

(Chen et al, Ophthalmologica 2012 DOI: 10.1159/000337840.) 

Latest Articles
Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

Read more...

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Read more...

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Read more...

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Read more...

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Read more...

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Read more...

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Read more...

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Read more...

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Read more...

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.

Read more...